Matricelf Ltd

ILA 240.70As of Sun 8 Nov 2026, 12:00 UTC
TASE:MTLFHealthcare
Country Israel
PE (Fwd) •••
TSR 5Y CAGR (18.70%)
Div yield —
ROE (209.99%)
Biotechnology
Beta (5Y) 0.33
PE TTM —
TSR TTM (41.49%)
Mkt cap ILS 79.66M
ROIC (110.74%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
ILA 233
(3.30%)
(78.61%)
Hold 4|4|6|9|6
4Q25
1Q26
2Q26
3Q26
Earnings per shareILS
2.43
2.55
2.52
2.81
16.50%
13.50%
12.03%
25.89%
RevenueILS M
5.365
5.535
5.703
5.570
9.02%
13.80%
16.72%
9.73%
Peers (US$24.41M)
Cap (US$)
PE
26.82M
—
15.25M
—
24.40M
—
Capital
TTM
5Y
10Y
Leveragex
0.488
—
0.012
EBIT/Intx
2.109
0.543
0.660
Own earn%
9.89
103.50
90.82
Sh yield%
39.86
54.62
50.20
Owners
Insiders/Inst%
11.13
76.11
Short interest%
2.15
SBC / revenue%
4.59
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
8–15
$1 testx
—
Incr. ROIC%
1